NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Animals
Apoptosis
Cells, Cultured
Disease Models, Animal
Dopaminergic Neurons
/ pathology
Glia Maturation Factor
/ genetics
Humans
Inflammasomes
/ metabolism
Mice
Mice, Knockout
NLR Family, Pyrin Domain-Containing 3 Protein
/ metabolism
Neurogenic Inflammation
Neuroglia
/ physiology
Parkinson Disease
/ immunology
GMF
MPTP
NLRP3 inflammasome
Parkinson’s disease
Journal
International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
22
01
2020
revised:
10
03
2020
accepted:
22
03
2020
pubmed:
8
4
2020
medline:
9
3
2021
entrez:
8
4
2020
Statut:
ppublish
Résumé
Neuroinflammation plays an active role in the pathogenesis of several neurodegenerative diseases, including Parkinson's disease (PD). Earlier studies from this laboratory showed that glia maturation factor (GMF), a proinflammatory mediator; is up-regulated in the brain in neurodegenerative diseases and that deficiency of GMF showed decreased production of IL-1β and improved behavioral abnormalities in mouse model of PD. However, the mechanisms linking GMF and dopaminergic neuronal death have not been completely explored. In the present study, we have investigated the expression of NLRP3 inflammasome and caspase-1 in the substantia nigra (SN) of human PD and non-PD brains by immunohistochemistry. Wild-type (WT) and GMF
Identifiants
pubmed: 32259702
pii: S1567-5769(20)30220-4
doi: 10.1016/j.intimp.2020.106441
pmc: PMC7255416
mid: NIHMS1582559
pii:
doi:
Substances chimiques
Glia Maturation Factor
0
Inflammasomes
0
NLR Family, Pyrin Domain-Containing 3 Protein
0
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
9P21XSP91P
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106441Subventions
Organisme : BLRD VA
ID : I01 BX002477
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG048205
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Références
Neurochem Int. 2013 Mar;62(4):379-88
pubmed: 23391521
Int J Biochem Cell Biol. 2013 Sep;45(9):2027-35
pubmed: 23830891
Proc Natl Acad Sci U S A. 1989 May;86(10):3901-5
pubmed: 2726756
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Mol Immunol. 2018 Nov;103:115-124
pubmed: 30248487
Nat Rev Immunol. 2010 Mar;10(3):210-5
pubmed: 20168318
Neuropathol Appl Neurobiol. 2012 Oct;38(6):572-81
pubmed: 22035352
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S17-20
pubmed: 22166424
Biochem J. 2015 Nov 1;471(3):323-33
pubmed: 26272943
Neuron. 2003 Sep 11;39(6):889-909
pubmed: 12971891
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20388-93
pubmed: 19918053
Nature. 2011 Jan 13;469(7329):221-5
pubmed: 21124315
J Neuroimmune Pharmacol. 2013 Jun;8(3):643-50
pubmed: 23397250
J Neurochem. 1991 Aug;57(2):483-90
pubmed: 1712830
Mol Neurodegener. 2016 Apr 16;11:28
pubmed: 27084336
J Neurochem. 2007 Apr;101(2):364-76
pubmed: 17250654
NPJ Parkinsons Dis. 2017 Oct 17;3:30
pubmed: 29057315
Brain Res. 1997 Feb 21;749(1):44-52
pubmed: 9070626
PLoS One. 2013;8(1):e55375
pubmed: 23383169
Neurochem Res. 2007 Jan;32(1):39-47
pubmed: 17151915
Mol Neurobiol. 2018 Sep;55(9):7132-7152
pubmed: 29383690
Acta Biochim Biophys Sin (Shanghai). 2013 Mar;45(3):170-8
pubmed: 23291291
Nature. 2006 Mar 9;440(7081):237-41
pubmed: 16407889
Arch Neurol. 1999 Jan;56(1):33-9
pubmed: 9923759
Mov Disord. 2020 Jan;35(1):20-33
pubmed: 31680318
J Neuroimmune Pharmacol. 2017 Dec;12(4):624-660
pubmed: 28466394
J Neurol Sci. 1990 Jul;97(2-3):273-93
pubmed: 2205710
Brain Res. 2008 May 7;1208:192-203
pubmed: 18395194
BMJ. 2004 Sep 11;329(7466):581-2
pubmed: 15361418
J Clin Immunol. 2010 Sep;30(5):628-31
pubmed: 20589420
J Immunol. 2018 May 1;200(9):3047-3052
pubmed: 29602772
Cell Death Differ. 2015 Oct;22(10):1676-86
pubmed: 25744023
Nature. 2013 Jan 31;493(7434):674-8
pubmed: 23254930
Immunity. 2013 Aug 22;39(2):311-323
pubmed: 23954133
Nat Rev Immunol. 2007 Jan;7(1):31-40
pubmed: 17186029
Behav Brain Res. 2019 Jan 1;356:483-489
pubmed: 29885849
Neurochem Res. 2001 Dec;26(12):1293-9
pubmed: 11885780
Nat Immunol. 2008 Aug;9(8):857-65
pubmed: 18604209
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11282-7
pubmed: 22733741
Neurochem Res. 2015 May;40(5):980-90
pubmed: 25754447
J Neurochem. 1993 Mar;60(3):914-20
pubmed: 8436977
Mol Neurobiol. 2017 Aug;54(6):4292-4302
pubmed: 27339879
J Immunol. 2009 Mar 1;182(5):3173-82
pubmed: 19234215
Cell Mol Immunol. 2016 Mar;13(2):148-59
pubmed: 26549800
PLoS Pathog. 2009 Dec;5(12):e1000510
pubmed: 20041168
J Neurosci. 2010 Nov 24;30(47):15811-20
pubmed: 21106820
Neuroscience. 2011 Oct 27;194:227-33
pubmed: 21835226
FASEB J. 2003 Oct;17(13):1957-9
pubmed: 12923073
J Immunol. 2011 Nov 15;187(10):5440-51
pubmed: 22003197
Annu Rev Immunol. 2009;27:519-50
pubmed: 19302047
J Neural Transm (Vienna). 2015 Oct;122(10):1409-19
pubmed: 25894287
Sci Transl Med. 2018 Oct 31;10(465):
pubmed: 30381407
FEBS Lett. 2012 Apr 5;586(7):1022-6
pubmed: 22569257